Glial cell line derived neurotrophic factor (GDNF) signals through a multicomponent receptor complex consisting of RET receptor tyrosine kinase and a member of GDNF family receptor a (GFRa). Recently, it was shown that tyrosine 1062 in RET represents a binding site for SHC adaptor proteins and is crucial for both RAS/mitogen activated protein kinase (MAPK) and phosphatidylinositol 3-kinase (PI3-K)/AKT signaling pathways. In the present study, we characterized how these two pathways diverge from tyrosine 1062, using human neuroblastoma and primitive neuroectodermal tumor cell lines expressing RET at high levels. In response to GDNF stimulation, SHC bound to GAB1 and GRB2 adaptor proteins as well as RET, and SHC and GAB1 were highly phosphorylated on tyrosine. The complex formation consisting of SHC, GAB1 and GRB2 was almost abolished by replacement of tyrosine 1062 in RET with phenylalanine. Tyrosine-phosphorylated GAB1 was also associated with p85 subunit of PI3-K, resulting in PI3-K and AKT activation, whereas SHC-GRB2-SOS complex was responsible for the RAS/ERK signaling pathway. These results suggested that the RAS and PI3-K pathways activated by GDNF bifurcate mainly through SHC bound to tyrosine 1062 in RET. Furthermore, using luciferase reporter-gene assays, we found that the RAS/ERK and PI3-K signaling pathways are important for activation of CREB and NF-kB in GDNF-treated cells, respectively. Oncogene (2000) 19, 4469 ± 4475.
Introduction
RET proto-oncogene codes for a receptor tyrosine kinase that represents a functional receptor for four related neurotrophic factors including glial cell linederived neurotrophic factor (GDNF), neurturin, artemin and persephin (see Airaksinen et al., 1999 for a review) . In addition to RET, these factors require glycosylphosphatidylinositol-linked cell surface proteins, called GDNF family receptor a1-4 (GFRa1-4), as ligand-binding components for intracellular signaling. In vitro binding study showed that GFRa1, GFRa2, GFRa3 and GFRa4 bind GDNF, neurturin, artemin and persephin with high speci®city, respectively. However, interestingly, these four related neurotrophic factors appear to be able to cross-talk through dierent GFRas in the presence of RET. For example, GDNF and neurturin almost equally activated RET in cells expressing both GFRa1 and RET Creedon et al., 1997; Jing et al., 1997) , and GDNF and artemin was also able to cause RET phosphorylation through GFRa2 and GFRa1, respectively (Baloh et al., , 1998 Jing et al., 1997; Sanicola et al., 1997) . In this respect, it is interesting to note that EketjaÈ ll et al. (1999) recently reported that RET and GFRa1 pre-assemble at cell surface without GDNF stimulation. Based on the results from sitedirected mutagenesis of GDNF, they proposed the presence of two distinct binding sites for GDNF, one formed by GFRa1 alone and another formed by a preassembled GFRa1-RET complex; the latter might lead to promiscuity in ligand-receptor speci®cities.
Gene knock out studies revealed that RET, GDNF and GFRa1 genes play crucial roles in the development of kidney and enteric nervous system, suggesting a tight coupling of GDNF and GFRa1 in RET signaling in vivo (Schuchardt et al., 1994; Moore et al., 1996; Pichel et al., 1996; Sanchez et al., 1996; Cacalano et al., 1998; Enomoto et al., 1998) . Neuturin7/7 and Gfra27/7 mice showed the drastic reduction of cholinergic innervation in the lacrimal and submandibular salivary glands as well as in the intestine (Heuckeroth et al., 1999; Rossi et al., 1999) . The Gfra37/7 mice exhibited severe defects in the superior cervical ganglion (SCG), whereas other ganglia appeared normal (Nishio et al., 1999) . These observations suggested that, despite promiscuity in ligandreceptor speci®cities in culture cells mentioned above, each of the GDNF family ligands has a rather speci®c function in vivo through GFRa-RET complex.
Intracellular signaling downstream of RET has been extensively studied using culture cell lines and primary neurons (van Weering and Bos, 1997; Chiariello et al., 1999; Xing et al., 1998b; Feng et al., 1999; Melillo et al., 1999; Murakami et al., 1999a,b; Soler et al., 1999; Trupp et al., 1999) . Binding of several adaptor proteins to phosphorylated tyrosine residues in its intracellular domain has been shown. For example, tyrosines at codons 905, 1015, 1062 and 1096 were identi®ed as docking sites for GRB7/GRB10, phospholipase Cg (PLCg), SHC/Enigma and GRB2, respectively (Asai et al., 1996; Borrello et al., 1996; Durick et al., 1998; Liu et al., 1996; Arighi et al., 1997; Lorenzo et al., 1997; Ohiwa et al., 1997; Alberti et al., 1998) . Of these tyrosines, we demonstrated that tyrosine 1062 is important for transforming activities of all multiple endocrine neoplasia (MEN) 2 mutant forms of RET examined so far (Asai et al., 1996; Ishiguro et al., 1999; Iwashita et al., 1999 Iwashita et al., , 2000 . SHC binding to RET through tyrosine 1062 leads to the activation of RAS/ MAPK signaling pathway. Interestingly, SegounCariou and Billaud (2000) recently reported that the PI3-K/AKT pathway was also activated through tyrosine 1062 in RET with a MEN 2A mutation (RET-MEN2A). In addition, the PI3-K/AKT pathway was shown to be critical for transforming activity of the RET-MEN2A mutant protein, although it remains unclear how this signaling pathway is activated through tyrosine 1062 in RET.
Here we show that the complex formation of GAB1 with SHC bound to tyrosine 1062, in response to GDNF, can lead to activation of PI3-K. In addition, we found that RAS/ERK and PI3-K/AKT signaling pathways activated by GDNF could be responsible for activation of CREB and NF-kB transcription factors, respectively.
Results

Activation of several signaling molecules depends on phosphorylation of tyrosine 1062 in RET activated by GDNF
We ®rst investigated whether GDNF stimulation can induce the activation of signaling molecules including AKT, ERK, JNK, p38MAPK and CREB in TGW human neuroblastoma cells expressing both RET and GFRa1 (Nozaki et al., 1998) . All of them were clearly phosphorylated in response to GDNF stimulation ( Figure 1a) .
To elucidate which tyrosine in the carboxyl-terminal sequence of RET is important for activation of these molecules, tyrosine at codon 981, 1015, 1029 or 1062 was replaced with phenylalanine ( Figure 1b) . The sequences surrounding tyrosines 981, 1015 and 1062 match the consensus sequences for binding of p85 subunit of PI3-K, PLCg and SHC, respectively. Each mutant RET gene was transfected into SK-N-MC human primitive neuroectodermal tumor cell line expressing GFRa1 and GFRa2 (data not shown), and transfectants expressing high levels of mutant RET proteins were established (Figure 1b) . Interestingly, phosphorylation of AKT, ERK, JNK, p38MAPK and CREB was markedly impaired by a mutation of tyrosine 1062 but not a mutation of tyrosine 981, 1015 or 1029 (Figure 1b) , indicating the importance of tyrosine 1062 for activation of all these signaling molecules. In addition, phosphorylation of PLCg was impaired by a mutation of tyrosine 1015 as expected (data not shown).
Characterization of complex formation of adaptor proteins via tyrosine 1062 in RET Since tyrosine 1062 in RET represents a docking site for SHC adaptor proteins (Asai et al., 1996; Arighi et al., 1997; Lorenzo et al., 1997) , we investigated which signaling molecules bind to SHC in response to GDNF. As shown in Figure 2a , in addition to RET and GRB2, GAB1 was clearly co-precipitated with SHC from lysates of TGW and SK-N-MC(RET) cells stimulated with GDNF. On the other hand, coprecipitation of p85 subunit of PI3-K ( Figure 2a ) and SOS (data not shown) with SHC was not found under our experimental conditions. When the lysate from SK-N-MC(RETY1062F) cells was used, co-precipitation of RET, GAB1 and GRB2 with SHC was almost undetectable (data not shown), showing that this complex formation depends on phosphorylation of tyrosine 1062. Furthermore, GAB1 was highly phosphorylated on tyrosine in GDNF-treated cells and phosphorylated 52 and 46 kDa SHC proteins appeared to be eciently coprecipitated with GAB1 ( Figure 2b ).
As we previously described, p85 subunit of PI3-K was associated with GAB1 in GDNF-treated cells (Figure 2c ), leading to activation of PI3-K (Murakami et al., 1999b) , whereas RET and SOS were not (data not shown). In addition, we found that GAB1 was associated with GRB2 in them (Figure 2c ), indicating Tyrosines at codons 981, 1015, 1029 and 1062 in human RET cDNA encoding a long isoform (1114 amino acids) were replaced with phenylalanine as previously described (Asai et al., 1996) . Each mutant RET gene was inserted into the expression vector and transfected into SK-N-MC human primitive neuroectodermal tumor cells by the calcium phosphate precipitation method. The lysates from established transfectants untreated or treated with GDNF for 10 min were subjected to Western blotting with the designated antibodies the complex formation of SHC, GRB2 and GAB1 in a GDNF-dependent manner. Association of p85 and GRB2 with GAB1 was not observed in GDNF-treated SK-N-MC(RETY1062F) cells (data not shown). On the other hand, the GRB2-SOS complex was detected in unstimulated cells and its amount appeared to increase by GDNF treatment (Figure 2d ). These ®ndings thus suggested that GRB2-SOS complex and GAB1 are recruited to SHC bound to tyrosine 1062 in RET after GDNF stimulation and could be responsible for activation of RAS and PI3-K, respectively ( Figure  5 ).
CREB activation by RAS/ERK pathway and NF-kB activation by PI3-K pathway
We next investigated activation of transcription factors, CREB and NF-kB, by GDNF. A recent report suggested the involvement of RAS/ERK pathway for CREB activation induced by GDNF (Feng et al., 1999) . Since it was shown that the PI3-K/AKT or p38MAPK signaling pathway was required for its activation by NGF, FGF or serum stimulation (Tan et al., 1996; Xing et al., 1998a; Du and Montminy, 1998) , we tested whether these two pathways are also involved in CREB activation by GDNF. To inhibit each signaling pathway, we treated TGW cells with a MEK1 inhibitor, PD98059, two p38MAPK inhibitors, SB203580 and SB202190, or two PI3-K inhibitors, wortmannin and LY294002. Speci®city of each inhibitor was con®rmed by Western blotting, although LY294002 inhibited p38MAPK phosphorylation as well as AKT phosphorylation (Figure 3 ). CREB phosphorylation was inhibited by PD98059 but not by SB203580, SB202190, wortmannin and LY294002 (Figure 3) .
In addition, transcription activity of CREB induced by GDNF was determined by CREB reporter-gene assay. We made two constructs containing three tandem repeats of CREB binding sequences (CRE) and herpes simplex virus thymidine kinase (TK) minimal promoter or SV40 promoter, immediately upstream of the luciferase gene (Figure 4a) . About 1.6-and 2.5-fold increase of its activity was observed in GDNF-treated TGW cells transfected with CRE-TK and CRE-SV40 constructs, respectively (Figure 4b,d) . As expected, this increase was almost completely inhibited by PD98059 but not by SB203580 and wortmannin, con®rming the importance of the RAS/ ERK signaling pathway on CREB activation. Figure 3 RAS/ERK signaling pathway-dependent CREB phosphorylation. TGW cells were serum-starved for 2 h and incubated in the absence or presence of each kinase inhibitor at the designated concentrations for 15 ± 20 min. Then, the cells were treated with GDNF for 10 min. Inhibitors other than wortmannin were added together with GDNF. Wortmannin was removed before addition of GDNF because its action as an inhibitor was irreversible. The resulting cell lysates were subjected to Western blotting with the designated antibodies. Anti-pTyr antibody detected the 175 kDa phosphorylated RET protein Figure 4 Luciferase reporter gene assay. (a) Constructs used for dual luciferase reporter assay. CREB (CRE) and NF-kB binding sequences were tandemly repeated three and four times upstream of the herpes simplex virus thymidine kinase (TK) minimal promoter or SV40 promoter and the ®re¯y luciferase gene, respectively. These sequences were inserted into the pGL3-basic vector (Promega). (b ± e) The plasmid vectors shown in (a) were cotransfected with pRL-TK plasmid carrying the renilla luciferase gene into TGW cells. After transfection, the cells were cultured for 48 h and incubated in the presence or absence of each kinase inhibitor for 15 ± 20 min. Then, the cells were treated with GDNF for 1 h. Inhibitors other than wortmannin were added together with GDNF as described in Figure 3 . All values were normalized by the activities of the renilla luciferase gene. Results represent averages from at least three independent experiments and bars indicate the standard error. Averages of luciferase activities without GDNF treatment in each experiment were set at 1.0. (d) Degradation and phosphorylation of IkBa. Serum-starved TGW cells were incubated with GDNF for the indicated time and the resulting cell lysates were subjected to Western blotting with anti-IkBa and anti-phosphoIkBa (pIkBa) antibodies Romashkova and Makarov (1999) recently reported that, upon PDGF stimulation, IkB kinase (IKK) associates with AKT and plays a crucial role in NFkB activation. Thus, we investigated whether GDNF induces NF-kB activation in a PI3-K-dependent manner. As shown in Figure 4f , Ik-Ba that is known to regulate NF-kB activity was rapidly phosphorylated and degraded in response to GDNF. NF-kB reportergene assay showed that GDNF induced about 1.4-and 3.5-fold increase of transcription activity of NF-kB in GDNF-treated TGW cells transfected with NF-kB-TK and NF-kB-SV40 constructs, respectively (Figure 4a,c  and e) . In contrast to the results from the CREB reporter-gene assay, wortmannin but not PD98059 and SB203580 almost completely inhibited the expression of the luciferase gene (Figure 4c,e) . When we used SK-N-MC cells for the NF-kB reporter-gene assay, no activation was observed after GDNF stimulation (data not shown), suggesting that RET expression is necessary for NF-kB activation.
Discussion
Tyrosine residues in the intracellular domain of receptor tyrosine kinases represent docking sites for speci®c adaptor proteins. By site-directed mutagenesis, we demonstrated that a mutation of tyrosine 1062 in RET markedly impaired the transforming activity of all multiple endocrine neoplasia (MEN) 2 mutant forms of RET, suggesting its importance on signal transduction for oncogenesis (Asai et al., 1996; Iwashita et al., 1999 Iwashita et al., , 2000 . Consistent with the fact that the amino acid sequence surrounding tyrosine 1062 matches the consensus sequence for binding of SHC SH2 and PTB domains, SHC binding to RET-MEN2A and RET-MEN2B mutant proteins was severely reduced by its mutation (Asai et al., 1996; Arighi et al., 1997; Lorenzo et al., 1997; Ohiwa et al., 1997; Geneste et al., 1999; Ishiguro et al., 1999) . SHC bound to RET further complexes with GRB2 adaptor proteins, leading to the activation of RAS/ERK pathway. Recently, it turned out that phosphorylation of tyrosine 1062 in RET is also crucial for activation of the PI3-K/AKT signaling pathway (SegounCariou and Billaud, 2000) , although the sequence surrounding tyrosine 1062 does not match the consensus sequence for binding of p85 subunit of PI3-K.
In the present study, it was demonstrated that, in response to GDNF stimulation, SHC was associated with GAB1 proteins in addition to GRB2 and RET. Since we recently reported that PI3-K activity was detected mainly in the GAB1 immunoprecipitate from the lysate of GDNF-treated cells (Murakami et al., 1999b) , association of SHC with GAB1 appears to be essential for the activation of PI3-K pathway through tyrosine 1062 in RET. Moreover, we found that GAB1 also complexes with GRB2 after GDNF treatment, indicating the presence of the complex formation consisting of SHC, GAB1 and GRB2 ( Figure 5 ). Although the sequence surrounding tyrosine 981 matches the consensus sequence for binding of p85 subunit of PI3-K, we were not able to detect its direct association with RET. This was consistent with the result that replacement of tyrosine 981 with phenylalanine did not impair AKT phosphorylation ( Figure  1b) .
On the other hand, GRB2-SOS complex was present in unstimulated cells at signi®cant levels. It has been well established that the recruitment of GRB2-SOS complex to SHC is involved in the activation of RAS/ ERK signaling pathway. As expected, a mutation of tyrosine 1062 in RET markedly impaired activation of ERK. Although tyrosine 1096 was also reported to be a binding site for GRB2 (Alberti et al., 1998) , deletion of this tyrosine did not impair transforming activity of RET-MEN2A and RET-MEN2B mutant proteins (Asai et al., 1996) as well as phosphorylation of ERK (our unpublished data). Thus, it seems likely that the PI3-K and RAS pathways activated by GDNF bifurcate mainly through SHC bound to tyrosine 1062 in RET (Figure 5) , and that contribution of tyrosine 1096 for the activation of RAS/ERK pathway could be small. In addition, it is possible that PI3-K is activated partially by RAS as previously described (Rodriguez-Viciana et al., 1994; van Weering et al., 1998) .
Several reports demonstrated CREB phosphorylation by GDNF and a possible involvement of the RAS/ERK pathway for its activation (Xing et al., 1998b; Feng et al., 1999; Trupp et al., 1999) . Since it has also been reported that the p38MAPK or PI3-K pathway was involved in CREB activation by FGF, NGF or serum stimulation (Tan et al., 1996; Du et al., 1998; Xing et al., 1998a) , we tested this possibility using kinase inhibitors. As a result we found that the RAS/ERK pathway but not the p38MAPK and PI3-K pathways is essential for CREB phosphorylation by GDNF. A luciferase reporter-gene assay also con®rmed the importance of the RAS/ERK pathway for its CRE binding activity. Although the RAS/ERK pathway is believed to be necessary for cell growth and dierentiation, it is interesting to note that recent reports showed the importance of CREB for survival of neurons (Bonni et al., 1999; Riccio et al., 1999) . In addition, we showed, for the ®rst time, NF-kB activation in GDNF-stimulated cells. In response to GDNF, Ik-Ba was rapidly phosphorylated and degraded. It is well known that phosphorylation and degradation of IkB are required for NF-kB activation. Taken together with the result from the luciferase reporter-gene assay with kinase inhibitors, it is likely that the PI3-K pathway is crucial for the transcriptional activity of NF-kB induced by GDNF ( Figure 5 ). Extensive studies revealed that the PI3-K/AKT pathway plays an important role in cell survival induced by neurotrophic factors (see Datta et al., 1999 for a review). However, interestingly, Segoun-Cariou and Billaud (2000) reported that the PI3-K/AKT pathway is also required for transforming activity of the RET-MEN2A mutant protein, although it was not demonstrated whether NF-kB activation is necessary for this activity. Thus, further analyses of the PI3-K/AKT pathway activated by GDNF could provide a new insight into intracellular signals responsible for cell transformation as well as survival of neurons.
Finally, the fact that JNK and p38MAPK were also activated through phosphorylated tyrosine 1062 suggests the possibility that unknown complex formation of adaptor proteins other than GRB2 and GAB1 may be involved in activation of these signaling molecules.
Materials and methods
Cell line
TGW human neuroblastoma and SK-N-MC human primitive neuroectodermal tumor cell lines were grown in RPMI medium supplemented with 10% fetal calf serum.
Antibodies
Anti-RET antibody was developed against the carboxylterminal 19 amino acids of the long isoform of RET as described previously (Nozaki et al., 1998) . Anti-phosphotyrosine monoclonal antibody and anti-GAB1 rabbit polyclonal antibody were purchased from Upstate Biotechnology Inc. (Lake Placid, NY, USA). Anti-phosphoERK1/2, anti-phosphop38MAPK, anti-phosphoAKT, anti-IkBa and anti-phosphoIkBa polyclonal antibodies were from New England Biolabs Inc. (Beverly, MA, USA). Anti-SHC and anti-GRB2 polyclonal antibodies and anti-p85 subunit of PI3-kinase monoclonal antibody were from Transduction Laboratories (Lexington, KY, USA). Anti-SOS, anti-CREB and anti-phosphoCREB antibodies were from Santa Cruz Biotechnology Inc. (Santa Cruz, CA, USA).
Western blotting
Cells were lysed in sodium dodecyl sulfate (SDS) sample buer (50 mM Tris-HCl (pH 6.8), 5 mM EDTA, 2% SDS, 10% glycerol, 20 mg/ml bromophenol blue (BPB), 10 mM iodoacetamide) with 80 mM dithiothreitol (DTT). Equal protein amounts of the lysates were subjected to SDSpolyacrylamide gel electrophoresis and transferred to polyvinylidene di¯uoride (PVDF) membranes (Nihon Millipore Kogyo, Tokyo). Membranes were blocked for 30 min at room temperature in 3% albumin in TPBS (phosphate buered saline containing 0.5% Tween-20) with gentle shaking and incubated with primary antibodies overnight at 48C. After washing the membranes with TPBS three times, they were incubated with the secondary antibodies conjugated to horseradish peroxidase (swine anti-rabbit IgG-HRP, rabbit anti-mouse IgG-HRP, Dako) for 1 h at room temperature. The reaction was examined by an enhanced chemiluminescence detection kit (ECL, Amersham, UK) according to the directions of the supplier.
Immunoprecipitation
Cells were grown subcon¯uently in 100 mm dishes and serum-starved for 2 h. Then the cells were stimulated with GDNF (100 ng/ml) for 10 ± 20 min, washed once with icecold phosphate-buered saline (PBS) and lysed in radioimmunoprecipitation assay (RIPA) buer (20 mM Tris-HCl, pH 7.5, 150 mM NaCl, 2 mM EDTA, 1% Nonidet P(NP)-40) containing 1 mM phenylmethylsulfonyl¯uoride, 0.5 mM sodium orthovanadate, 0.1 mM aprotinin and 1 mM leupeptin. The cell lysates were centrifuged at 15 000 r.p.m. for 30 min to remove cell debris and incubated with 2 mg of antibodies for 3 h at 48C. The resulting immunocomplexes were collected with Protein A sepharose (Sigma, St. Louis, MO, USA) and washed four times with RIPA buer. The complexes were eluted in SDS sample buer by boiling for 5 min and subjected to SDS-polyacrylamide gel electrophoresis. Separated proteins were transferred to PVDF membranes and reacted with antibodies. The reaction was examined by ECL (Amersham).
Dual luciferase reporter assay
Cells were plated at 1610 5 in 12-well tissue culture plates and incubated for 16 ± 18 h. Transfection was performed using lipofectamine (Gibco-BRL, Rockville, MD, USA) according to the manufacturer's instructions. In brief, 0.4 ml of opti-MEM (Gibco-BRL) containing 0.35 mg of the pGL3-basic vector DNA (Promega, Madison, WI, USA) with herpes simplex virus thymidine kinase (TK) minimal promoter or SV40 promoter and tandemly repeated CREB or NF-kB binding sequences (Figure 4a ) and 0.35 mg of pRL-TK vector as internal standard for transfection eciency and 3.0 ml of lipofectamine was applied to one well and incubated at 378C for 5 h. After incubation, 0.4 ml of RPMI 1640 with 20% FBS was added to each well. The media were replaced with fresh ones with 10% FBS 24 h after application of DNA solution. After further 24 h culture, transfected cells were harvested by lysis. Lysis buer and reagents used in the luciferase assay were supplied as dual luciferase assay kit (Promega). Fire¯y and renilla luciferase activities were measured by Lumicounter 700 (MicroTech Niti-on, Saitama, Japan) and transfection eciencies were normalized by the activity of renilla luciferase derived from the cotransfected pRL-TK plasmid.
